Refusal-To-Deal Corporate Exposure.
Refusal-to-Deal: Corporate Exposure
Refusal-to-deal refers to a situation where a company declines to supply goods, services, or access to facilities to another business or customer. While firms generally have freedom of contract, competition law (especially in the UK and EU context) imposes limits where such refusal harms competition or constitutes abuse of dominance.
Corporate exposure arises when refusal-to-deal practices lead to antitrust liability, regulatory penalties, civil damages, or reputational harm.
1. Legal Framework
(a) General Rule: Freedom to Contract
Businesses are ordinarily free to choose trading partners. However, this freedom is restricted where market power exists.
(b) Competition Law Constraints
Under:
- Chapter II of the Competition Act 1998 (UK)
- Article 102 TFEU (EU law)
A dominant firm must not:
- Refuse supply unfairly
- Exclude competitors
- Restrict market access
2. When Refusal-to-Deal Becomes Illegal
A refusal is unlawful where:
(a) Dominant Position Exists
Firm has substantial market power.
(b) Abuse of Dominance
Refusal leads to:
- Elimination of competition
- Consumer harm
- Market foreclosure
(c) Lack of Objective Justification
No valid reason such as:
- Credit risk
- Capacity constraints
- Legal compliance
3. Key Doctrines
(a) Essential Facilities Doctrine
A dominant firm must provide access to a facility essential for competition if denial eliminates competition.
(b) Constructive Refusal
Occurs where supply is technically offered but on unreasonable terms.
(c) Discriminatory Refusal
Supplying some parties but unjustifiably refusing others.
4. Leading Case Laws
1. United Brands Co v Commission (1978)
- A dominant banana supplier refused to supply a distributor.
- Held: Refusal without objective justification = abuse of dominance.
- Established duty not to arbitrarily cut off customers.
2. Commercial Solvents Corp v Commission (1974)
- Company stopped supplying raw materials to a competitor.
- Held: Refusal intended to eliminate competition is unlawful.
- Early recognition of anti-competitive foreclosure.
3. Oscar Bronner GmbH v Mediaprint (1998)
- Refusal to grant access to newspaper distribution system.
- Held: No abuse unless facility is indispensable and duplication impossible.
- Narrowed the essential facilities doctrine.
4. IMS Health GmbH v NDC Health GmbH (2004)
- Refusal to license copyrighted data structure.
- Held: Abuse exists where refusal prevents emergence of a new product and lacks justification.
5. Microsoft Corp v Commission (2007)
- Refusal to provide interoperability information.
- Held: Abuse due to restriction on innovation and competition.
- Confirmed that refusal can apply to intellectual property rights.
6. R v Independent Television Commission, ex parte TSW Broadcasting Ltd (1996)
- UK case involving regulatory refusal affecting market access.
- Highlighted fair access obligations in regulated industries.
7. British Midland Airways Ltd v Aer Lingus plc (2007)
- Refusal to grant access to airport slots.
- Demonstrated how refusal can distort market entry conditions.
8. GlaxoSmithKline Services v Commission (2009)
- Supply restrictions affecting parallel trade.
- Examined balance between commercial freedom and competition law.
5. Corporate Exposure and Risks
(a) Regulatory Penalties
- Heavy fines (up to 10% of global turnover)
- Investigations by CMA or European Commission
(b) Civil Liability
- Damages claims by affected competitors
- Injunctions requiring supply
(c) Structural Remedies
- Mandatory access obligations
- Licensing requirements
(d) Reputational Damage
- Loss of goodwill
- Market distrust
6. Defences and Justifications
A company may justify refusal where:
(a) Objective Justification
- Customer insolvency risk
- Capacity limitations
- Safety or regulatory compliance
(b) Efficiency Justifications
- Protecting innovation incentives
- Maintaining quality standards
(c) Proportionality
- Refusal must be necessary and proportionate
7. Sector-Specific Risks
(a) Digital Markets
- Platforms refusing API or data access
- Interoperability disputes
(b) Pharmaceuticals
- Refusal to supply generics
(c) Infrastructure
- Access to networks (telecom, transport, energy)
8. Governance and Compliance Strategies
(a) Competition Law Audits
- Assess dominance and market share
(b) Clear Supply Policies
- Transparent criteria for refusal
(c) Documentation
- Record reasons for refusal decisions
(d) Legal Review
- Pre-clearance for high-risk refusals
9. Critical Evaluation
Strengths of Legal Approach
- Protects market access and competition
- Prevents exclusionary conduct
- Encourages fairness in dominant firms
Weaknesses
- High threshold for proving abuse
- Legal uncertainty (especially “indispensability”)
- Balancing innovation vs access is complex
Conclusion
Refusal-to-deal is a high-risk area of competition law, particularly for dominant firms. While businesses retain contractual freedom, this is significantly constrained where refusal harms competition. Case law—from Commercial Solvents to Microsoft—demonstrates a gradual evolution toward balancing commercial autonomy with market fairness. Effective governance and compliance mechanisms are essential to mitigate corporate exposure and ensure lawful business practices.
RELATED Blog
comments